Sacituzumab Govitecan (IMMU-132), an Anti-Trop-2/SN-38Antibody–Drug Conjugate: Characterization and Efficacy in Pancreatic,Gastric, and Other Cancers.
Autor: | Cardillo, Thomas M., Govindan, Serengulam V., Sharkey, Robert M., Trisal, Preeti, Arrojo, Roberto, Donglin Liu, Rossi, Edmund A., Chien-Hsing Chang, Goldenberg, David M. |
---|---|
Zdroj: | Bioconjugate Chemistry; May2015, Vol. 26 Issue 5, p919-931, 13p |
Databáze: | Supplemental Index |
Externí odkaz: |